DIN 02452529 — APO-DARIFENACIN 15 MG
APO-DARIFENACIN is a tablet (extended-release) of Darifenacin marketed by APOTEX INC. The full Darifenacin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02452529
- Brand name
- APO-DARIFENACIN
- Active ingredient
- Darifenacin
- Strength
- 15 MG
- Dosage form
- TABLET (EXTENDED-RELEASE)
- Route
- ORAL
- Manufacturer
- APOTEX INC
- Health Canada status
- MARKETED
- Drug class
- Muscarinic M3 selective receptor antagonist (antimuscarinic)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Darifenacin products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02452510 | APO-DARIFENACIN | 7.5 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | MARKETED |
| 02273225 | ENABLEX | 15 MG | TABLET (EXTENDED-RELEASE) | SEARCHLIGHT PHARMA INC | MARKETED |
| 02273217 | ENABLEX | 7.5 MG | TABLET (EXTENDED-RELEASE) | SEARCHLIGHT PHARMA INC | MARKETED |
| 02491877 | JAMP DARIFENACIN | 15 MG | TABLET (EXTENDED-RELEASE) | JAMP PHARMA CORPORATION | MARKETED |
| 02491869 | JAMP DARIFENACIN | 7.5 MG | TABLET (EXTENDED-RELEASE) | JAMP PHARMA CORPORATION | MARKETED |